My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 442

    1.

    Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%.

    Pani LN, Nathan DM, Grant RW.

    Diabetes Care. 2008 Mar;31(3):386-90. Epub 2007 Dec 14.PMID: 18083790 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glycemic response to newly initiated diabetes therapies.

    Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Go AS, Selby JV.

    Am J Manag Care. 2007 Nov;13(11):598-606.PMID: 17988185 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

    Riedel AA, Heien H, Wogen J, Plauschinat CA.

    Pharmacotherapy. 2007 Aug;27(8):1102-10.PMID: 17655510 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

    Yurgin N, Secnik K, Lage MJ.

    Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    6.

    An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

    Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M.

    Diabetes Care. 2006 Jun;29(6):1282-7.PMID: 16732009 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

    Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR.

    Diabetes Care. 2005 May;28(5):995-1000.PMID: 15855556 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

    Jermendy G; Hungarian RECAP Group, Erdesz D, Nagy L, Yin D, Phatak H, Karve S, Engel S, Balkrishnan R.

    Health Qual Life Outcomes. 2008 Oct 31;6:88.PMID: 18976457 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.

    Lawrence DB, Ragucci KR, Long LB, Parris BS, Helfer LA.

    J Manag Care Pharm. 2006 Jul-Aug;12(6):466-71.PMID: 16925454 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.

    Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D.

    Diabetes Care. 2007 Apr;30(4):807-12. Epub 2007 Jan 26.PMID: 17259469 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Long-term efficacy of triple oral therapy for type 2 diabetes mellitus.

    Bell DS, Ovalle F.

    Endocr Pract. 2002 Jul-Aug;8(4):271-5.PMID: 12173913 [PubMed - indexed for MEDLINE]Related articles

    12.

    Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).

    McEwen LN, Bilik D, Johnson SL, Halter JB, Karter AJ, Mangione CM, Subramanian U, Waitzfelder B, Crosson JC, Herman WH.

    Diabetes Care. 2009 Jun;32(6):971-6. Epub 2009 Feb 19.PMID: 19228862 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.

    Riedel AA, Heien H, Wogen J, Plauschinat CA.

    Am J Manag Care. 2007 Aug;13(8):457-63.PMID: 17685826 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glycemic relapse in type 2 diabetes.

    Graber AL, Shintani AK, Wolff K, Brown A, Elasy TA.

    Endocr Pract. 2006 Mar-Apr;12(2):145-51.PMID: 16690461 [PubMed - indexed for MEDLINE]Related articles

    16.

    Oral antidiabetic medication adherence and glycemic control in managed care.

    Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS.

    Am J Manag Care. 2008 Feb;14(2):71-5.PMID: 18269302 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Contemporary analysis of secondary failure of successful sulfonylurea therapy.

    Nichols GA, Alexander CM, Girman CJ, Kamal-Bahl SJ, Brown JB.

    Endocr Pract. 2007 Jan-Feb;13(1):37-44.PMID: 17360299 [PubMed - indexed for MEDLINE]Related articles

    18.

    Managing type 2 diabetes: going beyond glycemic control.

    Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO.

    J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19.PMID: 18597582 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM.

    Henricsson M, Janzon L, Groop L.

    Diabetes Care. 1995 Dec;18(12):1571-6.PMID: 8722053 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

    Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE; Sitagliptin 036 Study Group.

    Diabetes Care. 2007 Aug;30(8):1979-87. Epub 2007 May 7. Erratum in: Diabetes Care. 2008 Aug;31(8):1713. PMID: 17485570 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity